New Vivus Ch. 11 Plan Offers Stockholders Drug Royalties
By Jeff Montgomery ( November 12, 2020, 2:55 PM EST) -- Biotech company Vivus Inc. rolled out an amended Chapter 11 plan in Delaware that would grant participating former stockholders payments from a new subsidiary formed to distribute available royalties from a drug prospect that equity investors previously branded as undervalued....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.